Anbio Biotechnology (NNNN) Short-term Investments (2023 - 2025)

Historic Short-term Investments for Anbio Biotechnology (NNNN) over the last 3 years, with Q2 2025 value amounting to $8080.5 billion.

  • Anbio Biotechnology's Short-term Investments changed N/A to $8080.5 billion in Q2 2025 from the same period last year, while for Jun 2025 it was $8080.5 billion, marking a year-over-year change of. This contributed to the annual value of $1294.0 for FY2024, which is 6034.32% down from last year.
  • Per Anbio Biotechnology's latest filing, its Short-term Investments stood at $8080.5 billion for Q2 2025.
  • In the past 5 years, Anbio Biotechnology's Short-term Investments ranged from a high of $8080.5 billion in Q2 2025 and a low of $1294.0 during Q4 2024
  • Its 3-year average for Short-term Investments is $2693.5 billion, with a median of $3263.0 in 2023.
  • Examining YoY changes over the last 5 years, Anbio Biotechnology's Short-term Investments showed a top increase of 6034.32% in 2024 and a maximum decrease of 6034.32% in 2024.
  • Over the past 3 years, Anbio Biotechnology's Short-term Investments (Quarter) stood at $3263.0 in 2023, then plummeted by 60.34% to $1294.0 in 2024, then soared by 624459196190.57% to $8080.5 billion in 2025.
  • Its last three reported values are $8080.5 billion in Q2 2025, $1294.0 for Q4 2024, and $3263.0 during Q4 2023.